Skip to Content
GENEX begins whole-genome molecular testing service for people concerned about rare, intractable "Nanbyo" diseases
  • Dec 22, 2022

GENEX begins whole-genome molecular testing service for people concerned about rare, intractable "Nanbyo" diseases

  • Dec 22, 2022

Related content

Owned Media
Owned Media
At a Glance
Integrated Report / Annual Report
Financial Result Related Materials
  1. Monex Group, Inc.
  2. News
  3. IR News
  4. GENEX begins whole-genome molecular testing service for people concerned about rare, intractable "Nanbyo" diseases
  • header-content
  • header-content

  • footer-content